FDA Approves New IL-31 Drug for Eczema

(MedPage Today) -- The FDA approved nemolizumab (Nemluvio) in combination with prescription topical agents for the treatment of moderate-to-severe atopic dermatitis, drugmaker Galderma announced.
A monoclonal antibody that targets interleukin...